$CELC Cashflow Statement | Understand Stock

$CELC

$65.80 +$0.55 (0.84%) Close

$CELC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash and cash equivalents used in operations:
Depreciation
Stock-based compensation
Issuance of common stock, licensing agreement
Amortization of debt issuance costs and discount
PIK interest
Payment-in-kind interest
Loss on sale of fixed assets
Non-cash operating lease, net
Non-cash operating lease expense
Change in accrued interest income
Changes in operating assets and liabilities:
Payroll tax receivable
Prepaid assets and deposits
Prepaid clinical trial costs
Other current and non-current assets
Accounts payable
Accrued expenses
Accrued clinical trial costs
Other accrued expenses

Net cash used in operating activities
Cash flows from investing activities:
Proceeds from maturities of investments
Purchases of investments
Purchases of property and equipment
Proceeds from sale of property and equipment
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from employee stock purchases
Proceeds from exercise of common stock options
Proceeds from follow-on offering, net of underwriting discounts and offering costs
Proceeds from exercise of common stock warrants
Proceeds from convertible debt, net of debt issuance costs of $6,246 and $0 during the years ended December 31, 2025 and 2024, respectively
Proceeds from note payable, net of debt issuance costs of $2,255 and $2,438 during the years ended December 31, 2025 and 2024, respectively
Gross proceeds from an ATM offering
Proceeds from an ATM offering, net of commission fees and offering costs
Proceeds from equity offering, net of underwriting discounts and offering costs
Proceeds from an ATM offering, net of issuance costs
Proceeds from pre-funded warrants, net of offering costs
Payments for secondary registration statement costs
Payments for debt issuance costs
Payments for finance leases
Net cash provided by financing activities

Net change in cash and cash equivalents
Cash and cash equivalents:
Beginning of period
End of period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for operating leases
Supplemental disclosures of non-cash investing and financing activities:
Registration statement costs included in accounts payable
Common stock warrants issued with the note payable transaction
Property and equipment included in accounts payable
Deferred financing, offering and registration statement costs included in accounts payable
Issuance of common stock warrants and final fee recognized as discount to note payable

Comments